XORTX Therapeutics
(NASDAQ:XRTX)
$3.61
0.01[0.28%]
At close: Mar 28
$3.61
0[0.00%]
After Hours: 8:51AM EDT
Consensus Rating1
Buy
Highest Price Target1
$14.00
Lowest Price Target1
$14.00
Consensus Price Target1
$14.00

XORTX Therapeutics Stock (NASDAQ:XRTX), Analyst Ratings, Price Targets, Predictions

XORTX Therapeutics Inc has a consensus price target of $14, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Alliance Global Partners and Alliance Global Partners on January 4, 2024 and December 9, 2021. With an average price target of $12.5 between Alliance Global Partners and Alliance Global Partners, there's an implied 246.26% upside for XORTX Therapeutics Inc from these 2 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Jan
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Alliance Global Partners

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for XORTX Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
01/04/2024XRTXBuy Now
XORTX Therapeutics
$3.61287.81%Alliance Global Partners
James Molloy
$9 → $14MaintainsBuyGet Alert
12/09/2021XRTXBuy Now
XORTX Therapeutics
$3.61204.71%Alliance Global Partners
James Molloy
→ $99Initiates → BuyGet Alert

FAQ

Q

What is the target price for XORTX Therapeutics (XRTX)?

A

The latest price target for XORTX Therapeutics (NASDAQ: XRTX) was reported by Alliance Global Partners on January 4, 2024. The analyst firm set a price target for $14.00 expecting XRTX to rise to within 12 months (a possible 287.81% upside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for XORTX Therapeutics (XRTX)?

A

The latest analyst rating for XORTX Therapeutics (NASDAQ: XRTX) was provided by Alliance Global Partners, and XORTX Therapeutics maintained their buy rating.

Q

When was the last upgrade for XORTX Therapeutics (XRTX)?

A

There is no last upgrade for XORTX Therapeutics.

Q

When was the last downgrade for XORTX Therapeutics (XRTX)?

A

There is no last downgrade for XORTX Therapeutics.

Q

When is the next analyst rating going to be posted or updated for XORTX Therapeutics (XRTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of XORTX Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for XORTX Therapeutics was filed on January 4, 2024 so you should expect the next rating to be made available sometime around January 4, 2025.

Q

Is the Analyst Rating XORTX Therapeutics (XRTX) correct?

A

While ratings are subjective and will change, the latest XORTX Therapeutics (XRTX) rating was a maintained with a price target of $9.00 to $14.00. The current price XORTX Therapeutics (XRTX) is trading at is $3.61, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.